Financhill
Sell
39

ALXO Quote, Financials, Valuation and Earnings

Last price:
$1.31
Seasonality move :
55.36%
Day range:
$1.27 - $1.37
52-week range:
$0.40 - $2.27
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
8.93x
P/B ratio:
1.61x
Volume:
74.6K
Avg. volume:
226.7K
1-year change:
-21.3%
Market cap:
$72.1M
Revenue:
--
EPS (TTM):
-$2.03

Earnings Data

Next earnings date for ALXO
Mar 05
2026
Most recent earnings per share
-$0.41
Missed by $0.41
(Nov 7/2025)
Consensus Estimate
--
(Nov 7/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

ALXO Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/05/2026 Q4 -- -- -- -$0.32 --
11/07/2025 Q3 -- -- -$0.41 -- --
08/12/2025 Q2 -- -- -$0.49 -$0.31 -$0.18
05/08/2025 Q1 -- -- -$0.58 -$0.31 -$0.27
03/06/2025 Q4 -- -- -$0.55 -$0.39 -$0.16
11/07/2024 Q3 -- -- -$0.58 -$0.66 $0.08
08/08/2024 Q2 -- -- -$0.76 -$0.70 -$0.06
05/09/2024 Q1 -- -- -$0.71 -$0.71 -$0.00
03/07/2024 Q4 -- -- -$0.92 -$0.84 -$0.08
11/13/2023 Q3 -- -- -$1.24 -$0.89 -$0.35
08/10/2023 Q2 -- -- -$0.84 -$0.86 $0.02
05/11/2023 Q1 -- -- -$0.74 -$0.80 $0.06
03/09/2023 Q4 -- -- -$0.75 -$0.88 $0.13
11/08/2022 Q3 -- -- -$0.87 -$0.74 -$0.13
08/08/2022 Q2 -- -- -$0.81 -$0.62 -$0.20
05/09/2022 Q1 -- -- -$0.60 -$0.68 $0.08
03/18/2022 Q4 -- -- -$0.70 -$0.61 -$0.09
11/11/2021 Q3 -- -- -$0.61 -$0.49 -$0.12
08/12/2021 Q2 -- -- -$0.40 -- --
05/17/2021 Q1 -- -- -$0.35 -- --
03/24/2021 Q4 -- -- -$0.50 -- --
11/12/2020 Q3 -- -- -$0.36 -- --
08/27/2020 Q2 -- -- -$0.40 -- --
03/31/2020 Q1 -- -- -$0.21 -- --
12/31/2019 Q4 -- -- -$0.40 -- --
09/30/2019 Q3 -- -- -$0.19 -- --
06/30/2019 Q2 -- -- -$0.24 -- --
03/31/2019 Q1 -- -- -$0.23 -- --

ALX Oncology Holdings, Inc. Earnings Questions

  • How Much did ALX Oncology Holdings, Inc. Generate in Revenue Last Quarter?

    ALX Oncology Holdings, Inc. reported -- worth of top line sales in its most recent quarter.

  • Did ALX Oncology Holdings, Inc. Beat Earnings Last Quarter?

    ALX Oncology Holdings, Inc. announced earnings per share of -$0.41 which represents a miss of analyst forecast a -- per share.

  • Is ALX Oncology Holdings, Inc. Profitable?

    ALX Oncology Holdings, Inc. reported -$153K that represents -$0.00 per share over the last quarter.

  • What is the Analyst Consensus for ALX Oncology Holdings, Inc. EPS Next Year?

    ALX Oncology Holdings, Inc.'s earnings are forecast to decrease from -$2.58 per share to -$1.56 per share next year representing a decrease of -39.64%.

  • When is ALX Oncology Holdings, Inc.'s Earnings Date?

    ALX Oncology Holdings, Inc.'s next earnings date is March 5, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
59
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 65x

Buy
55
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
72
GLTO alert for Dec 27

Galecto, Inc. [GLTO] is up 16.92% over the past day.

Sell
20
SMX alert for Dec 27

SMX (Security Matters) Plc [SMX] is down 15.76% over the past day.

Sell
11
CDNAF alert for Dec 27

Canadian Tire Corp. Ltd. [CDNAF] is down 10% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock